{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:41Z","timestamp":1761986501176,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jaip.2016.11.011","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T00:00:30Z","timestamp":1482796830000},"page":"831-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance"],"prefix":"10.1016","volume":"5","author":[{"given":"Sara M.","family":"May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan S.","family":"Motosue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.11.011_bib1","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: AIDSinfo. 2015 [updated September 10, 2015; cited August 23, 2015]. Available from: https:\/\/aidsinfo.nih.gov\/guidelines\/html\/4\/adult-and-adolescent-oi-prevention-and-treatment-guidelines\/321\/pcp. Accessed August 23, 2015."},{"key":"10.1016\/j.jaip.2016.11.011_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A\u00a0randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Bozzette","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2016.11.011_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archinte.1996.00440020081010","article-title":"A\u00a0meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens","volume":"156","author":"Ioannidis","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2016.11.011_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9343(96)00008-3","article-title":"Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim\/sulfamethoxazole","volume":"100","author":"Beumont","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2016.11.011_bib5","first-page":"341","article-title":"Comparative trial of dapsone\u00a0versus trimethoprim\/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia","volume":"5","author":"Blum","year":"1992","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jaip.2016.11.011_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002030-199301000-00010","article-title":"Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients","volume":"7","author":"Carr","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2016.11.011_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/j.1875-9114.1998.tb03904.x","article-title":"Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone","volume":"18","author":"Holtzer","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2016.11.011_bib8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-199303000-00008","article-title":"Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals","volume":"7","author":"Jorde","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.jaip.2016.11.011_bib9","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:12:52Z","timestamp":1761973972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219816305694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213219816305694"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.011","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}